Immutep Limited (ASX:IMM)
0.2550
-0.0100 (-3.77%)
Nov 6, 2025, 4:10 PM AEST
Immutep Market Cap
Immutep has a market cap or net worth of 375.34 million as of November 6, 2025. Its market cap has decreased by -12.53% in one year.
Market Cap
375.34M
Enterprise Value
247.27M
Revenue
5.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 375.34M, an increase of 10,146.88%. That is a compound annual growth rate of 17.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 375.34M | -29.35% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | 269.22M | 166.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.76B |
| Pro Medicus | 26.54B |
| Cochlear | 18.64B |
| Sonic Healthcare | 10.23B |
| Ramsay Health Care | 7.11B |
| Ansell | 5.18B |
| Telix Pharmaceuticals | 5.13B |
| Mesoblast | 2.94B |